EZH2 inactivation in RAS-driven myeloid neoplasms hyperactivates RAS-signaling and increases MEK inhibitor sensitivity

Detalles Bibliográficos
Autores principales: Berg, Johannes Lorenz, Perfler, Bianca, Hatzl, Stefan, Uhl, Barbara, Reinisch, Andreas, Pregartner, Gudrun, Berghold, Andrea, Penz, Thomas, Schuster, Michael, Geissler, Klaus, Prokesch, Andreas, Müller-Tidow, Carsten, Hoefler, Gerald, Kashofer, Karl, Wölfler, Albert, Sill, Heinz, Caraffini, Veronica, Zebisch, Armin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102185/
https://www.ncbi.nlm.nih.gov/pubmed/33589750
http://dx.doi.org/10.1038/s41375-021-01161-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102185/
https://www.ncbi.nlm.nih.gov/pubmed/33589750
http://dx.doi.org/10.1038/s41375-021-01161-0

Ejemplares similares